New Investments

South African Biotech Startup Immobazyme Secures $1.3 Million in Funding

| Article

South African biotechnology company Immobazyme, founded in 2019 as a spin-off from Stellenbosch University, has secured $1.3 million in a recent funding round.

The funding was led by the The University Technology Fund (UTF) and University of Stellenbosch Enterprises.

Immobazyme leverages precision fermentation technology to develop high-value protein ingredients.

Their product range includes growth factors for the burgeoning cell-cultured meat industry, enzymes like dextranase for the sugar industry, and food ingredients for the food and beverage sector.

With this funding boost, Immobazyme plans to double the size of its production facility and expand its capacity.

This investment highlights the growing interest in alternative protein sources and the potential of precision fermentation technology.

Immobazyme’s expansion plans position them to play a significant role in these developing markets.


Related Articles

Register Now

Empower Africa Times Newsletter

Share :

“We are delighted to partner with ISA to support the development of solar energy in Africa,” said Alain Ebobissé, CEO of Africa50. “This partnership will help to accelerate the deployment of solar energy in Africa and improve the lives of millions of Africans,” he added.

You may also like...

© 2021 Empower Africa. All rights reserved.